Stimulation of PKD1 activity by phorbol ester promoted the Golgi-localization of wild-type and phospho-mutants of OSBP but did not affect OSBP-dependent SM synthesis. Only when wildtype or kinase-dead PKD1 was overexpressed was 25-hydroxycholesterol-activated SM synthesis inhibited. We conclude that OSBP and PKD1 form a complex that inhibits both the oxysterol-dependent activity of OSBP at the ER-Golgi and activation of PKD1. Formation of the complex was independent of PKD1 activity and phosphorylation of OSBP.
| INTRODUCTION
The secretory activity of the Golgi apparatus is regulated by the spatial and temporal organization of intrinsic lipid biosynthetic and transport pathways.
1 Sphingomyelin (SM) and glycosphingolipids are synthesized in the trans-Golgi and trans-Golgi network (TGN) where they coalesce with cholesterol to form liquid-ordered domains that mediate trafficking of select cargo to the apical surface of cells. [2] [3] [4] The synthesis of sphingolipids in the Golgi apparatus is dependent on delivery of ceramide from the endoplasmic reticulum (ER) by the ceramide transport protein (CERT) and glucosylceramide transport by phosphatidylinositol 4-phosphate adaptor protein-2. 5, 6 The recruitment of these sphingolipid transport proteins to Golgi membranes relies on phosphatidylinositol 4-phosphate (PtdIns-4P), a low abundance lipid that is also essential for clathrin-dependent secretion from the TGN. PtdIns-4P levels in Golgi cisternae are co-ordinately controlled by the activity of phosphatidylinositol 4-kinases IIIβ, IIα and
IIIα and the PtdIns-4P phosphatase Sac1. 7, 8 Protein kinase D (PKD) has overarching control of PtdIns-4P and sphingolipid homeostasis in the Golgi apparatus. Growth regulatory signals stimulate PKD phosphorylation and activation of PI4KIIIβ. 9 The resultant increase in Golgi-associated PtdIns-4P recruits the pleckstrin homology (PH) domain of CERT to ER membrane contact sites (MCS) to increase the supply of ceramide for glycosphingolipid and SM synthesis, which in turn generates diacylglycerol for PKD activation. 10 Activated PKD eventually imposes feedback inhibition on CERT by phosphorylating S315, which triggers phosphorylation of an adjunct serine-rich region and a conformation change that prevents PH domain binding to PtdIns-4P. 11, 12 Oxysterol-binding protein (OSBP) is a lipid transport protein at ER-Golgi MCS that is also phosphorylated by PKD. 13 OSBP is the founding member of a 12-gene family that share a conserved C-terminal OSBP homology domain (OHD) that binds cholesterol, oxysterols, PtdIns-4P and phosphatidylserine. [14] [15] [16] Most OSBP family members also have a two phenylalanines in an acid tract (FFAT) motif that binds vesicle-associated membrane-associated protein (VAP) in the ER and a N-terminal PH domain. In the case of OSBP, the PH domain binds PtdIns-4P and ADP-ribosylation factor 1 on the transGolgi/TGN, while the FFAT motif anchors the protein to the ER. Dual membrane interaction at ER-Golgi MCS is central to the ability of OSBP to transfer ligands between these organelles 17 and recruit other lipid transport proteins. 18, 19 PKD phosphorylates human OSBP at S240, a site that is conserved across species. 13 Based on imaging studies using a phospho-mimetic S240D mutant, the primary effect of PKD phosphorylation was to diminish association of OSBP with the TGN in oxysterol-treated and cholesterol-depleted cells. Interestingly, OSBP S240D association with the cis-and medial-Golgi was unaffected. Consistent with its lack of TGN association, OSBP-S240D did not support VSVG secretion to the plasma membrane. These results suggest that phosphorylation of OSBP and CERT by PKD is a negative feedback mechanism to co-ordinate the cessation of cholesterol transport and sphingolipid synthesis at the TGN.
This negative feedback model does not detail how phosphorylation affects OSBP activities that regulate its interaction with ER-Golgi MCS, such as cholesterol/oxysterol/PtdIns-4P binding by the OHD or PtdIns-4P binding by the PH domain. As well, there are conditions under which OSBP activity at ER-Golgi MCS is apparently stimulated by PKD phosphorylation. A recent study showed that removal of PtdIns-4P from the Golgi apparatus in response to acute elevation of sphingolipid flux using a short-chain ceramide was associated with PKD phosphorylation of OSBP. 20 In cells treated with tetradecanylphorbol acetate (TPA), a potent PKD activator that stimulates OSBP phosphorylation, 13 OSBP translocated from an ER-cytoplasmic compartment to the Golgi apparatus. 21 These results showing the apparent recruitment of OSBP to an ER-Golgi MCS under conditions where it is phosphorylated by PKD suggests a more complex mode of regulation.
To define the regulatory interactions between PKD and OSBP, we focused on the functionality of the PKD phospho-site in OSBP.
Because OSBP was identified as a scaffold protein for phosphatases that regulate extracellular signal-regulated kinase (ERK) activity, 22 we also investigated whether a physical interaction between OSBP and PKD had regulatory implications. Using recombinant OSBP and cultured cell models, we show that PKD phosphorylation of OSBP had minimal impact on binding of its lipid and protein ligands, as well as oxysterol-dependent activity at MCS. Rather, a physical interaction between the proteins affected OSBP recruitment to the Golgi apparatus and negatively regulated S916 autophosphorylation and activation of the PKD1 isoform.
2 | RESULTS
| In vitro activity of PKD phospho-site mimetics of OSBP
To determine the impact of PKD phosphorylation on OSBP activity in vitro, mimetics of the dephosphorylated (S242A) and phosphorylated state (S242D) were expressed and purified from Sf21 insect cells ( Figure 1A Figure 1H ). It was evident that similar amounts of OSBP and the phospho-mimetics co-immunoprecipitated with VAP-A.
OSBP translocation to ER-Golgi MCS in response to 25OH or cholesterol depletion activates the CERT-dependent delivery of ceramide to the Golgi for SM synthesis. 19 The capacity of OSBP phospho-mimetics to activate CERT and SM synthesis was deter- transiently expressing wild-type and OSBP phosphomimetics were subject to immunofluorescence microscopy using a PtdIns-4P-specific monoclonal antibody ( Figure S1 , Supporting Information). As shown previously, OSBP expression reduced Golgi PtdIns-4P relative to mock-transfected cells. 17, 23 However, expression of the S240A or S240D mutants also reduced PtdIns-4P detection suggesting the PKD phosphorylation has minimal impact on PtdIns-4P levels in the Golgi apparatus.
| PKD phosphorylation of OSBP is independent of other phospho-sites
In addition to the PKD phospho-site, OSBP is phosphorylated on two serine-rich motifs (designated sites 1 and 2) that regulate localization to MCS. 24 Site 1 (five serine residues) is adjacent to the FFAT domain, while site 2 (three serine residues) is located between the PH domain and the PKD phospho-site ( Figure 3A ). Phosphorylation of sites 1 and 2 are independently regulated but the specific combination of site 1 dephosphorylation and site 2 phosphorylation prevents OSBP from accessing MCS and renders it nonfunctional for CERT regulation. 24 Interplay between the three phospho-sites in OSBP was determined using phospho-mimetic mutants. Increased phosphorylation of site Figure 3D ). Site 1/site 2 double phospho-mutants that mimicked constitutively phosphorylated (S5E/S3D) and dephosphorylated species (S381A/S3A) were also substrates for PKD1 (arrows) ( Figure 3E ).
Thus, the three phosphorylation sites in OSBP appear to be independently regulated.
| PKD1 and OSBP interaction is independent of phosphorylation status
While analyzing OSBP phosphorylation following immunoprecipitation and immunoblotting with the PKD phospho-motif antibody, we observed ORP4/OSBP2 is the most closely related family member to OSBP and has a putative PKD phospho-site (LQRSLT) that coincides with the site in OSBP. When tested in a PKD substrate assay, ORP4 was not phosphorylated; however, it weakly co-immunoprecipitated with active and kinasedead PKD1 ( Figure 4C ).
We utilized a series of OSBP deletion and point mutants to map the site of interaction with PKD1 ( Figure 5A ). These OSBP mutants have been previously characterized [26] [27] [28] 
| OSBP inhibits PKD1 autophosphorylation
We examined whether the physical interaction between OSBP and PKD1 has regulatory implications. To test whether OSBP expression alters PKD1 activity, S916 phosphorylation of endogenous PKD1 was used as a readout of kinase activity in CHO-shNT and -shOSBP cells ( Figure 7A,B) . Following PKD1 recruitment to membranes by The distribution and intensity of other proteins detected with the PKD phospho-motif antibody did not appear to change with OSBP expression ( Figure 7E ). These data suggest that OSBP could negatively regulate autophosphorylation and activation of PKD1.
| Regulation of OSBP by PKD1 is independent of phosphorylation
TPA activates PKD activity and localization to the Golgi apparatus, which also triggers phosphorylation and Golgi localization of OSBP. 
| DISCUSSION
Phosphorylation of site-1 and site-2 motifs in the linker regions between the PH and OHD domains of OSBP regulates binding to sterols and VAP-A, and partitioning into ER-Golgi MCS. 24 The linker region also harbors a single PKD phosphorylation site that negatively regulates the interaction of OSBP with the TGN and vesicular transport to the plasma membrane. 13 Here, we endeavored to identify a mechanism for PKD regula- exchange activity of OSBP, 17 we cannot rule out the possibility that PKD phosphorylation affects the sum of these activities at ER-Golgi MCS.
However, expression of wild-type and OSBP phospho-mimetics in HeLa cells caused a similar reduction in Golgi PtdIns-4P levels suggesting the PKD phosphorylation does not affect PI-P4 transport ( Figure S1 ).
The concept that phosphorylation of OSBP by PKD has minimal effect on Golgi localization or function of OSBP was also supported by results using TPA, a potent activator of PKD that stimulates the phosphorylation and translocation of OSBP to the Golgi apparatus. 13, 21 TPA caused the expected translocation and colocalization of OSBP with PKD1; however, OSBP phospho-site mutants also translocated indicating that PKD phosphorylation of OSBP was not necessary (Figures 8 and 9 ). Despite the extensive Golgi localization of OSBP in response to TPA treatment, there was only a 50% increase in SM synthesis (compared to >200% in response to 25OH) that was independent of OSBP expression. Thus, a PKDdependent mechanism could direct OSBP to the Golgi apparatus where it has an alternate function, such as Rab11-dependent cholesterol export from recycling endosomes 32 or endosome-ER tethering involved in retromer budding. 33 Results with TPA contrast a recent finding using p38 inhibitors in which a direct relationship was demonstrated between site 1 phosphorylation of OSBP and activation of SM synthesis at the Golgi apparatus. interferes with kinase activation. 37 Kinase-dead PKD1 is poorly phosphorylated on S916 suggesting that OSBP preferentially associates with an inactive form and inhibits autophosphorylation.
The interaction with PKD1 also negatively regulated OSBP activity based on the inhibition of OSBP-dependent activation of SM synthesis by transient expression of active or kinase-dead PKD1 (Figure 10) . A simple explanation is that PKD1 sequesters OSBP at another Golgi site or inhibits its activity at MCS. However, we cannot exclude the possibly that PKD1 activity has pleotropic effects on Golgi function that indirectly inhibits OSBP activity. These regulatory interactions with PKD1 have parallels to OSBP regulation of ERK. 22 In that case, OSBP forms a nonmembrane associated, sterol-regulated scaffold complex with serine and tyrosine ERK phosphatases that dissembles under low sterol conditions leading to increased phospho-ERK. The OSBP-PKD1 complex differs in that the interaction is not affected by sterols ( Figure 6 ). is also serine-rich and primed by phosphorylation, 25 regulated by the cellular content of cholesterol and SM, 11, 21 and regulates protein activity. 24 In summary, sterol-dependent activities of OSBP at ER-Golgi MCS
were not regulated by PKD1 phosphorylation. Instead, OSBP and PKD1
formed an inhibitory complex that could be important in regulation of sphingolipid and cholesterol homeostasis in the Golgi secretory pathway. 
| Baculovirus expression and purification of OSBP
Baculovirus expression of rabbit OSBP and OSBP-RR 109,110 EE was described elsewhere. 23, 24 The rabbit and human OSBP protein sequence has 98% overall conservation, and 100% conservation of 
| Immunoprecipitation
Co-immunoprecipitation of VAP-A and OSBP was previously described. 27 Briefly, CHO-shOSBP cells expressing cDNAs-encoding OSBP or OSBP phospho-mutants were lysed in PBS containing 5 mM KCl, 2 mM EDTA, 2 mM EGTA and 0.5% (vol/vol) Triton X-100, and precleared by centrifugation at 14 000g for 15 minutes at 4 C. VAPA was immunoprecipitated from supernatants using a polyclonal antibody 27 and protein A-Sepharose, washed three times with PBS containing 0.1% (wt/vol) Triton X-100, and resuspended in SDS-PAGE sample buffer. Immunoprecipitates were separated by SDS-8% PAGE and immunoblotted for OSBP using monoclonal 11H9. treatment with or without 25OH (6 μg/mL) for 6 hours as described in section 4. Results are the mean and SD of four experiments (*P < 0.05, **P < 0.01) monoclonal antibody (to detect transfected PKD1). A secondary IRDye-800-conjugated secondary antibody was used in conjunction with phospho-S916 and PKD phospho-motif antibodies, while a secondary IRDye-600-conjugated antibody was used with PKD1 and HA primary antibodies. Phosphorylation status of PDK1 was expressed as the ratio of fluorescence intensity for the phospho-antibody vs total PKD1 protein signal on the same blot (quantified using an Odyssey Imaging System).
| Sphingolipid synthesis
The OSBP-dependent stimulation of ceramide transport and sphingolipid synthesis was measured by a [ 
